Pharmacogenetics of intravenous and oral busulfan in hematopoietic cell transplant recipients.

Pharmacogenetics of intravenous and oral busulfan in hematopoietic cell transplant recipients.

Item
http://www.wikidata.org/entity/Q35053340
Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation.Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia.Population pharmacokinetics of busulfan in pediatric and young adult patients undergoing hematopoietic cell transplant: a model-based dosing algorithm for personalized therapy and implementation into routine clinical use.Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning.Variation in prescribing patterns and therapeutic drug monitoring of intravenous busulfan in pediatric hematopoietic cell transplant recipientsEffect of weight and maturation on busulfan clearance in infants and small children undergoing hematopoietic cell transplantation.Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.An analysis of the therapeutic benefits of genotyping in pediatric hematopoietic stem cell transplantation.Pharmacometabonomic Prediction of Busulfan Clearance in Hematopoetic Cell Transplant Recipients.Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients.Prediction of Intravenous Busulfan Clearance by Endogenous Plasma Biomarkers Using Global Pharmacometabolomics.Physiologically based pharmacokinetic modelling of Busulfan: a new approach to describe and predict the pharmacokinetics in adults.Predictive performance of a physiologically based pharmacokinetic model of busulfan in children.GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study.Population pharmacokinetics and pharmacodynamics of busulfan with GSTA1 polymorphisms in patients undergoing allogeneic hematopoietic stem cell transplantation.New insights into the pharmacokinetics of intravenous busulfan in children with sickle cell anemia undergoing bone marrow transplantation.Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review.
P2860

Pharmacogenetics of intravenous and oral busulfan in hematopoietic cell transplant recipients.

Item
http://www.wikidata.org/entity/Q35053340
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pharmacogenetics of intravenou ...... ic cell transplant recipients.
@ast
Pharmacogenetics of intravenou ...... ic cell transplant recipients.
@en
type
label
Pharmacogenetics of intravenou ...... ic cell transplant recipients.
@ast
Pharmacogenetics of intravenou ...... ic cell transplant recipients.
@en
prefLabel
Pharmacogenetics of intravenou ...... ic cell transplant recipients.
@ast
Pharmacogenetics of intravenou ...... ic cell transplant recipients.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Pharmacogenetics of intravenou ...... ic cell transplant recipients.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932